NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/10/2025
Voltar para busca
Dado oficial do USPTO
HY2CARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
25/10/2025
Tipo de marca
Verbal
Classes Nice
5, 10, 44
Data de depósito
20/10/2021
Data de registro
04/07/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/07/2023
Última transação
25/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
26
Localização do titular
NL
Examinador
BROWN,TINA
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Hy2Care B.V.
Representantes
Bradley M. Stohry Reichel Stohry Dean LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human and animal body for cartilage repair and treatments; medicated hydrogels resorbable by the human and animal body for pain management and inflammation reduction; medicated hydrogels resorbable by the human and animal body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillersteeth filling material; surgical glues and sealants
Classe 10
Medical devicesinjection needles; medical devicessyringes; medical devices for injection of liquid components in the human and animal bodyinjection needles; medical devices for injection of liquid polymers in the human and animal bodyinjection needles; medical devices for injection of hydrogels in the human and animal bodyinjection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human and animal bodyinjection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human and animal bodyinjection instruments with needles; medical devices for supply of dermal fillers to the human bodyinjection needles; medical devices for supply of dental fillers to the human and animal bodyinjection needles; medical devices for supply of dental fillers to the human and animal bodysyringes; medical devices for application of surgical glues and sealants to the human and animal body; diagnostic apparatus for medical purposesultrasound diagnostic apparatus; diagnostic apparatus for medical purposesX-ray diagnostic apparatus; cell culture instruments for medical usecell culture chambers
Classe 44
Medical servicescartilage repair in the human body; medical servicespain management and inflammation reduction in the human body; medical servicesbone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment servicessurgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogels
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/04/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/10/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/10/2023
FIMP
FINAL DISPOSITION PROCESSED
05/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
19/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/04/2023
PUBO
PUBLISHED FOR OPPOSITION
18/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/03/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2023
RFNP
REFUSAL PROCESSED BY IB
23/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2022
RFRR
REFUSAL PROCESSED BY MPU
03/08/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/08/2022
CNRT
NON-FINAL ACTION WRITTEN
01/08/2022
DOCK
ASSIGNED TO EXAMINER
27/07/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/04/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/02/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HY2CARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.